Overview

Supervised Asthma Medication in Schools (SAMS)

Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that school-based, direct supervision of daily controller therapy will result in more effective asthma control, as assessed by the Asthma Control Questionnaire than usual care. Additionally, as the result of enhanced asthma control and resulting decrease in health care utilization, school-based, direct supervision of daily controller therapy will result in lower cost per quality-adjusted life year (QALY) gained than usual care.
Phase:
Phase 4
Details
Lead Sponsor:
University of Arizona
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Albuterol